AXQ Capital’s Twist Bioscience TWST Stock Holding History

AXQ Capital’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,143	Closed	-$226K	–	831
2025 Q2	$226K	Buy	+6,143	New	+$212K	0.07%	435

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

AXQ Capital's TWST Position: Q3 2025 in Review

AXQ Capital sold out of Twist Bioscience (TWST) in Q3 2025, closing a stake of 6,143 shares — an estimated $226K sold.

AXQ Capital first reported a position in TWST in Q2 2025 and held it in 1 quarter. The position peaked at $226K in Q2 2025. 238 funds tracked by Wall St. Rank hold TWST as of Q3 2025.

AXQ Capital reported no remaining Twist Bioscience position as of Q3 2025 after selling out during the quarter.
AXQ Capital sold 6,143 Twist Bioscience shares in Q3 2025, an estimated $226K.
AXQ Capital first reported a position in Twist Bioscience in Q2 2025 and held it in 1 quarter.
AXQ Capital's Twist Bioscience position peaked at $226K in Q2 2025.
238 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2025.

Based on AXQ Capital's 13F filing for Q3 2025, filed 10 Nov 2025.